A Stroke Management Market is a medical disorder in which a blood clot plugs blood vessels in the brain, interrupting blood flow and causing cell death. According to the American Stroke Association's guidelines, there are three types of strokes: ischemic stroke (an obstruction within a blood artery delivering blood to the brain), hemorrhagic stroke (weakened blood vessel rapture owing to high blood pressure), and transient ischemic attack (TIA) (identified by a temporary clot).
Stroke Management Market can be caused by medical disorders like high blood pressure, diabetes, or heart disease, as well as lifestyle choices like smoking, a sedentary lifestyle, alcohol misuse, obesity, and a variety of other things. Stroke is also influenced by uncontrollable factors such as advancing age, male sex, heredity, and ethnicity. According to the World Health Organization (WHO), stroke was the second biggest cause of death globally in 2015, behind heart disease, accounting for 11.8 percent of all fatalities.
Global Stroke Management Market Taxonomy:
Diagnostics
Computed Tomography Scan (CT scan)
Echocardiography
Magnetic Resonance Imaging (MRI)
Carotid Ultrasound
Nuclear Medicine Imaging
Cerebral Angiography
Electrocardiography
Other Diagnostics
Drug Therapy Products
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive
Intravenous Thrombolytic products
Interventional Stroke Management Systems
Surgical and Endovascular Systems
Cerebrovascular Endovascular Systems
On the basis of application, the global stroke management market is segmented into:
Ischemic Stroke
Hemorrhagic Stroke
On the basis of end-user, the global stroke management market is segmented into:
Hospitals
Clinics
Ambulatory Surgical Centers
Diagnostic Laboratories
Retail Pharmacies
Online Pharmacies
Other End Users
Global Stroke Management Market - Competitors
Other major companies contributing to the stroke management market include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, GE Healthcare, GlaxoSmithKline Plc, Medtronic Plc, Merck & Co., Inc., and Cardinal Health.
0 Comments